Frontiers in Microcirculation: Control Processes and Clinical Applications

Microcirculation (2010) 17 , 159–163. doi: 10.1111/j.1549‐8719.2010.00028.x Abstract This edition of Microcirculation presents five current and emerging perspectives of the microcirculation in development, health, and disease. The onset of blood flow and pressure are central to cardiovascular development. These hemodynamic forces are explored in light of underlying molecular signaling pathways that affect vascular and cardiac cell shape and proliferation. Shear‐induced strain exerted on the plasma membrane and cytoskeleton is transmitted to cell nuclei and thereby affects gene activation through mechanotransduction. Altered stiffness or disturbed surfaces of aberrant vascular cells may affect an array of vasculopathies through altered gene expression. The endothelium is both a site and source for inflammatory responses triggered by cardiovascular risk factors often mediated through reactive oxygen species and angiotensin II. Tumor microenvironments are disturbed with abnormal growth and remodeling of blood and lymphatic vessels. More effective targeting strategies for delivering anti‐angiogenic and cytotoxic agents are being developed through advances in intravital imaging. Blood flow control requires both vasodilation and vasoconstriction to be coordinated along and among arterioles and feed arteries. Evolving insights into signaling pathways between smooth muscle cells and endothelial cells illuminate how such processes can be affected in vasculopathies. These timely reviews provide a novel reference for advancing research frontiers in microcirculation.